Overview of the New York State program for prescription drug benefits.

E. Lennard, P. Feinberg
{"title":"Overview of the New York State program for prescription drug benefits.","authors":"E. Lennard, P. Feinberg","doi":"10.1093/AJHP/51.23.2944","DOIUrl":null,"url":null,"abstract":"New York State's prescription drug benefits program is described. The Empire Plan, a part of the New York State Health Insurance Program, includes a prescription drug benefits program. The prescription drug program began in 1986 and covers more than 700,000 people. In 1988 the state started a therapeutic drug-use-evaluation (DUE) program in correct with the supplier, Health Information Designs, a subsidiary of ValueRx Pharmacy Program. In 1991 the partnership with ValueRx was expanded to include patient profilling and physician education. In 1993 the state implemented a prior-authorization program for certain high-technology drugs, also administered by ValueRx. New York's public work force is heavily unionized, and the unions have been deeply involved in program design and vendor selection. Program participants have access to a large network of community pharmacies. The program also provides mail-order service. Quality is at the center of the state's and the unions' prescription drug program philosophy. Saving money is also a major objective; savings totaling $19.5 million were realized from 1988 through 1993 under the partnership between the state and ValueRx. The Empire Plan's prescription drug benefits program is building quality and saving money by integrating DUE, prior authorization, education, community pharmacy, and mail-order service.","PeriodicalId":7452,"journal":{"name":"American journal of hospital pharmacy","volume":"23 1","pages":"2944-8"},"PeriodicalIF":0.0000,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of hospital pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/AJHP/51.23.2944","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

New York State's prescription drug benefits program is described. The Empire Plan, a part of the New York State Health Insurance Program, includes a prescription drug benefits program. The prescription drug program began in 1986 and covers more than 700,000 people. In 1988 the state started a therapeutic drug-use-evaluation (DUE) program in correct with the supplier, Health Information Designs, a subsidiary of ValueRx Pharmacy Program. In 1991 the partnership with ValueRx was expanded to include patient profilling and physician education. In 1993 the state implemented a prior-authorization program for certain high-technology drugs, also administered by ValueRx. New York's public work force is heavily unionized, and the unions have been deeply involved in program design and vendor selection. Program participants have access to a large network of community pharmacies. The program also provides mail-order service. Quality is at the center of the state's and the unions' prescription drug program philosophy. Saving money is also a major objective; savings totaling $19.5 million were realized from 1988 through 1993 under the partnership between the state and ValueRx. The Empire Plan's prescription drug benefits program is building quality and saving money by integrating DUE, prior authorization, education, community pharmacy, and mail-order service.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
概述纽约州处方药福利计划。
描述了纽约州的处方药福利计划。帝国计划是纽约州健康保险计划的一部分,包括处方药福利计划。处方药项目始于1986年,覆盖了70多万人。1988年,该州与供应商健康信息设计公司(ValueRx Pharmacy program的子公司)共同启动了一项治疗性药物使用评估(DUE)计划。1991年,与ValueRx的合作扩大到包括患者分析和医生教育。1993年,该州对某些高科技药物实施了预先授权计划,同样由ValueRx管理。纽约的公共部门工作人员是高度工会化的,工会一直深入参与项目设计和供应商选择。项目参与者可以使用一个庞大的社区药房网络。该项目还提供邮购服务。质量是州政府和工会处方药项目理念的核心。省钱也是一个主要目标;1988年至1993年,在州政府与ValueRx的合作下,共节省了1,950万美元。帝国计划的处方药福利项目通过整合DUE、事先授权、教育、社区药房和邮购服务来提高质量并节省资金。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Rifampin. ASHP statement on the pharmacy and therapeutics committee. Access to health care. ASHP statement on the pharmacy and therapeutics committee. Final rule issued on Medicaid DUR and patient counseling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1